FDA Approves First Treatment for Oral Ulcers Associated with Rare Inflammatory Disease

Patients battling the rare, inflammatory disorder known as Behçet’s Disease now have a new treatment option. Celgene’s plaque psoriasis drug, Otezla, was approved for the treatment of adult patients with oral ulcers associated with Behçet’s.